CBD Supports Pain Relief in Participants Suffering from Dental Pain
Written by Chrystal Moulton, Staff Writer. At 180min, both CBD groups had a maximum pain reduction of 73% from baseline. (more…)
Written by Chrystal Moulton, Staff Writer. At 180min, both CBD groups had a maximum pain reduction of 73% from baseline. (more…)
Written by Dr. Clara Sartor. CBD use was associated with improvements in pain (83%), physical function (66%), and sleep quality (66%). Additional controlled, randomized clinical trials will help further assess the risk-to-benefit profile and efficacy of this botanical modality for arthritis and arthralgia. (more…)
Written by Chrystal Moulton, Staff Writer. Compared to delta-9-tetrahydrocannabinol (THC) inhaled alone or in combination with cannabidiol (CBD), inhaled CBD demonstrated a reduction in psychotic-like symptoms in light users of cannabis.
(more…)
Written by Angeline A. De Leon, Staff Writer. Study results show that medical cannabis, when used as a palliative treatment for cancer patients, appears to be a well-tolerated, effective and safe option for patients coping with malignancy related symptoms. (more…)
Written by Angeline A. De Leon, Staff Writer. CBD significantly blocked transient osteoarthritis pain, while prophylactic CBD treatment significantly prevented the later development of pain and nerve damage in the OA joints of a rat model. (more…)
Written by Dr. Patrick Massey, MD, PhD. A recent study demonstrated that cannabis can have a significant benefit in reducing the pain and improving the quality of life in people with fibromyalgia. (more…)
Written by Joyce Smith, BS. Researchers, using informal surveys of patients enrolled in the medical cannabis program, discovered that a significant proportion of chronic pain patients reported having replaced their opioid prescriptions with cannabis for treating their chronic pain.
(more…)
Written by Angeline A. De Leon, Staff Writer. Study results demonstrate that an anxiety-reducing dose of cannabidiol does not appear to interfere with the sleep cycle of healthy volunteers. (more…)
Written by Joyce Smith, BS. △9–tetrahydrocannabinol (Δ9-THC), the main psychoactive component in cannabis, significantly impacts placental and fetal development when used during pregnancy.
(more…)
Written by Joyce Smith, BS. Three consecutive days of oral cannabidiol (CBD) solution significantly reduced cravings and anxiety induced by drug cues in people with heroin use disorder who were abstinent from the drug. (more…)
Written by Joyce Smith, BS. Cannabis treatment was shown to be safe and to improve ASD symptoms and quality of life in the participating autistic patients. (more…)
Written by Joyce Smith, BS. Migraine frequency was significantly decreased with the use of medical marijuana. (more…)
Written by Angeline A. De Leon, Staff Writer. A fourteen-week treatment of 20 mg/kg daily of a pharmaceutical formulation of purified cannabidiol significantly diminished drop seizures in the participating patients with Lennox-Gastaut syndrome compared to the control group. (more…)
Written by Angeline A. De Leon, Staff Writer. A 6-week cannabidiol intervention of 300 mg/day significantly improved Quality of Life scores in study participants with Parkinson’s disease compared to a 75 mg/day intervention or placebo. (more…)
Written by Angeline A. De Leon, Staff Writer. Compared to the control, participating subjects with schizophrenia had a significantly greater reduction in psychotic symptoms after six weeks of treatment with cannabidiol. (more…)
Written by Joyce Smith, BS. Cannabidiol, an extract from Cannabis stevia, significantly reduced the frequency of convulsive seizures in the 52 participating children and young adults with Dravet syndrome.
(more…)